- Home
- CLPT vs CRVS Comparison
CLPT vs CRVS Comparison
Compare CLPT & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- CRVS
- Stock Information
- Founded
- CLPT 1998
- CRVS 2014
- Country
- CLPT United States
- CRVS United States
- Employees
- CLPT N/A
- CRVS N/A
- Industry
- CLPT Medical/Dental Instruments
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- CRVS Health Care
- Exchange
- CLPT Nasdaq
- CRVS Nasdaq
- Market Cap
- CLPT 317.4M
- CRVS 305.4M
- IPO Year
- CLPT N/A
- CRVS 2016
- Fundamental
- Price
- CLPT $10.49
- CRVS $5.75
- Analyst Decision
- CLPT Strong Buy
- CRVS Strong Buy
- Analyst Count
- CLPT 3
- CRVS 4
- Target Price
- CLPT $27.67
- CRVS $15.00
- AVG Volume (30 Days)
- CLPT 375.5K
- CRVS 518.7K
- Earning Date
- CLPT 08-12-2025
- CRVS 08-07-2025
- Dividend Yield
- CLPT N/A
- CRVS N/A
- EPS Growth
- CLPT N/A
- CRVS N/A
- EPS
- CLPT N/A
- CRVS N/A
- Revenue
- CLPT $33,593,000.00
- CRVS N/A
- Revenue This Year
- CLPT $22.34
- CRVS N/A
- Revenue Next Year
- CLPT $25.50
- CRVS N/A
- P/E Ratio
- CLPT N/A
- CRVS N/A
- Revenue Growth
- CLPT 19.68
- CRVS N/A
- 52 Week Low
- CLPT $9.76
- CRVS $2.54
- 52 Week High
- CLPT $19.22
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- CLPT 44.46
- CRVS 65.10
- Support Level
- CLPT $10.42
- CRVS $5.28
- Resistance Level
- CLPT $10.88
- CRVS $5.64
- Average True Range (ATR)
- CLPT 0.52
- CRVS 0.30
- MACD
- CLPT -0.01
- CRVS 0.03
- Stochastic Oscillator
- CLPT 22.75
- CRVS 77.70
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).